$5.73
-0.07 (-1.21%)
USD · as of 2026-08-21 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where SCLX is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional
Held by 2 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC) · FINRA short interest 1.8 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Enhanced Safety Laser Hair Removal SystemNCT00441948Hair reduction as counted 1-3 months after each treatment session, depending on the treated area.Non-randomized · Single-masked · Treatment | Not applicable | Unknown status | Device: Peterio | Hirsutism, Hypertrichosis | 10 | — | 2007-03-01 |
| Enhanced Safety Aesthetic Laser SystemNCT00495443Hair, vascular lesions and wrinkles reduction as counted 1-3 months after each treatment session, depending on the treated area.Non-randomized · Single-masked · Treatment | Not applicable | Unknown status | Device: Peterio | Hirsutism, Hypertrichosis, Telangiectases, Rhytides | 25 | — | 2007-07-03 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-21